(OTCBB: ACTC)
A biotechnology company focused on applying stem cell technology in the field of regenerative medicine to bring effective, patient-specific therapies to the bedside
Advanced Cell Technology: Category Archive for Company News

Advanced Cell Technology's Executive Invited to Present Today to FDA Advisory Committee on Cellular Tissue Therapies

Advanced Cell Technology Platform Yields Over 140 Cell Types from Human Embryonic Stem Cells

Barbara Walters' ABC Network Television Special Highlights Role that Advanced Cell Technology's Embryonic Stem Cells Play in Preventing Aging

Advanced Cell Technology to be Featured Tonight on ABC Television's Special Report ''Live to 150, Can You Do It? Secrets to Living Longer''

Advanced Cell Technology Completes Private Placement

Advanced Cell Technology Announces Catheter Supply Agreement with Biologics Delivery Systems Group

Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V.

Advanced Cell Technology Demonstrates Efficient Generation of Functional Hepatocytes (Liver Cells) From Human Embryonic Stem Cells

Advanced Cell Technology Announces Presentation of Results from Myoblast Study at ISCTR World Symposium

Advanced Cell Technology Announces Completion of Pre-IND Meeting with the FDA for RPE Therapy for the Treatment of Retinal Degenerative Disease

Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos

Advanced Cell Technology Awarded Grant from the NIH

Advanced Cell Technology Issues Letter to Investors

Advanced Cell Technology Seeking International Partners for Its Therapeutic Programs

Advanced Cell Technology's Chief Executive Officer Scheduled to Be Interviewed By Bloomberg Television Tonight

Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial

ACT's Myoblast Trial Selected as Late Breaking Trial for AHA Conference

Advanced Cell Technology Completes Acquisition of Mytogen, Inc.

Advanced Cell Technology Completes $10 Million Private Placement

Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.

Advanced Cell Technology Applauds Inclusion of Stem Cell Provision In $152 Billion Federal Funding Measure

Advanced Cell Technology and Wisconsin Alumni Research Foundation Announce Commercial License Agreement

Advanced Cell Commends Massachusetts Governor Deval Patrick's Decision to Push to Reverse Stem Cell Research Restrictions

Advanced Cell Technology hESC lines to be used in CIRM-Funded Study To Test Development of New Therapies For Heart Disease

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

Advanced Cell Applauds $3 Billion Stem Cell Research Program, Proposition 71, Upheld Monday By A California Appeals Court

Advanced Cell Technology Acquires Intellectual Property Assets of Infigen, Inc.

Advanced Cell Technology Announces Collaboration with the Casey Eye Institute at Oregon Health and Science University

Advanced Cell Technology Awarded Federal Grant from National Institutes of Health to Accelerate Embryonic Stem Cell Research

Advanced Cell Technology's William Caldwell Interviewed By Bloomberg Television

Advanced Cell Technology Invited to Deliver Keynote Address at Prestigious International Stem Cell Therapy and Regenerative Medicine Conference in London

Advanced Cell Technology Executives to Present Keynote Address and Company Presentation at New York Society of Security Analysts (NYSSA) Conference

Advanced Cell Technology's Robert Lanza, M.D., to Deliver Keynote Address at the University of Florida's Vision Research Symposium on December 7, 2006

Advanced Cell Technology Names Current Chief Executive Officer William M. Caldwell IV as Chairman of the Board

Advanced Cell Technology Scientist Dr. Robert Lanza Invited to Address The National Academy of Sciences at Stem Cell Policy Meeting

Advanced Cell Technology to Present Stem Cell Programs at Rodman & Renshaw's Annual Healthcare Conference in New York

New York Times Cites Advanced Cell's Review in Nature On an Approach to Generate Human Embryonic Stem Cells Without Destroying the Embryo

ACTC Reports

ACTC Offer to Distribute

ACTC Financings Totaling Over $13 Million

Dr. Lanza Testifies

Chairman of ACTC Testifies

ACTC Announces Financing Commitments

ACTC Stem Cells that Maintains Developmental Potential of Embryo

"ACTC" Proposed Financing